NemoCoin (NEMO) will be launching its token sales with ProBit Global!
⯈ IEO Duration
23 May 2019 (Thursday), 03:00 UTC to 28 May 2019 (Tuesday), 02:59 UTC
⯈ Price
NEMO will be priced at $0.04/NEMO.
⯈ Bonuses
- Buy NEMO using PROB, Get 15% Bonus
Users will gain 15% more NEMO by purchasing NEMO through PROB. PROB is the token of ProBit Global, which offers its holders multiple airdrops and benefits.
- Buy NEMO using USDT, BTC, ETH, and XRP, Get 10% Bonus
Users will gain 10% more NEMO by purchasing NEMO through USDT, BTC, ETH, and XRP.
⯈ KYC Verification Notice
All participants of NemoCoin's token sale are required to complete KYC verification.
⯈ About NemoLab (http://nemolab.kr/)
NemoLab is the developer of an advanced blockchain-based technology which combines the research capabilities of top university research institutes in Korea to provide next-generation blockchain platform research and technology. Their highly capable third-generation R&D blockchain platform called Cardano which links Bitcoin and Ethereum and has a capacity of 3 billion users.
ABOUT PROBIT GLOBAL
ProBit Global is a Top 20 crypto exchange worldwide servicing crypto enthusiasts with unlimited access to trade and buy Bitcoin, Ethereum and 800+ altcoins in 1000+ markets.
PROBIT GLOBAL IS A BRAND TRUSTED BY MILLIONS OF USERS
200,000+ community members
1,000,000+ monthly active users
3,000,000 monthly web visitors
50,000,000 users on partnering aggregators and wallets such as CoinMarketCap
User interface of Multilingual website supporting 46 different languages
Marketing and community support in 11 key languages
Join our active programs and get huge benefits!
- Trading Fee Discount: Buy PROB, pay trading fees with PROB & get as low as 0.03% trading fee
- Referral Program: Earn 10-30% of trading fees for referring friends to ProBit
- ProBit Exclusive: Subscribe to 50% off Top 200 tokens
- Auto Hold Campaigns: Hold tokens and get 6% annualized returns
ProBit Global: www.probit.com
ProBit Telegram: https://t.me/ProBitGlobalOfficial
Comments
0 comments
Article is closed for comments.